Table 1.
Baseline characteristics | Open-access phase intervention participants (N = 139) |
---|---|
Age (years) | 59.3 ± 9.6 [33, 77] |
Weight (kg) | 97 ± 20 [51, 170] |
Body mass index (kg/m2) | 33.1 ± 6.0 [18.8, 54.1] |
Duration of diabetes (years) | 17 ± 8 [2, 43] |
Duration of insulin use (years) | 9 ± 6 [0, 40] |
Screening HbA1c | |
mmol/mol | 71.8 ± 10.5 [59, 103] |
% | 8.72 ± 0.96 [7.5, 11.6] |
Self-reported blood glucose frequency per day | 3.6 ± 1.29 [1, 10] |
Insulin (total daily dose) | |
Basal units (n = 124) | 38.0 ± 21.0 |
Bolus units (n = 115) | 51.7 ± 30.4 |
CSII units (n = 5) | 56.5 ± 39.5 |
Open-access phase intervention participants N (%) |
|
---|---|
Gender (male) | 88 (63%) |
Ethnicity | |
White | 134 (96%) |
Black | 1 (1%) |
Asian/Pacific Islander | 1 (1%) |
Other | 3 (2%) |
Diabetes management | |
Insulin pen device | 130 (94%) |
CSII | 8 (6%) |
Insulin syringe | 1 (1%) |
Previous CGM use | 10 (7%) |
Employment status | |
Employed (n = 136) | 56 (41%) |
Not employed/retired/other (n = 136) | 80 (59%) |
Insulin management training | |
<1 year ago | 41 (29%) |
>1 year ago | 93 (67%) |
Carbohydrate counting training | |
<1 year ago | 40 (29%) |
>1 year ago | 49 (35%) |
Bolus dose titration | |
Based on meal content (n = 138) | 89 (64%) |
Based on current glucose level (n = 138) | 108 (78%) |
Using sliding scale (n = 138) | 53 (38%) |
Values in table are presented as the mean ± standard deviation (SD) with the range in square brackets or as the number with the percentage in parenthesis, as appropriate
CGM Continuous glucose monitoring, CSII continuous subcutaneous insulin infusion, HbA1c glycated hemoglobin